Total Payments
$5,840
2024 Payments
$777.62
Companies
22
Transactions
180
Medicare Patients
2,224
Medicare Billing
$176,351
Payment Breakdown by Category
Food & Beverage$5,695 (97.5%)
Education$145.23 (2.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,695 | 175 | 97.5% |
| Education | $145.23 | 5 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,150 | 32 | $0 (2020) |
| Novo Nordisk Inc | $1,035 | 28 | $0 (2024) |
| Lilly USA, LLC | $647.27 | 26 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $602.91 | 7 | $0 (2024) |
| PFIZER INC. | $427.34 | 29 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $278.95 | 10 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $200.31 | 4 | $0 (2023) |
| Gilead Sciences, Inc. | $200.03 | 2 | $0 (2018) |
| Amarin Pharma Inc. | $166.85 | 4 | $0 (2022) |
| AbbVie Inc. | $160.53 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $777.62 | 32 | Boehringer Ingelheim Pharmaceuticals, Inc. ($278.95) |
| 2023 | $755.20 | 25 | E.R. Squibb & Sons, L.L.C. ($178.19) |
| 2022 | $747.98 | 19 | AstraZeneca Pharmaceuticals LP ($245.79) |
| 2021 | $65.26 | 4 | Novo Nordisk Inc ($23.69) |
| 2020 | $342.75 | 19 | Janssen Pharmaceuticals, Inc ($128.57) |
| 2019 | $749.92 | 18 | Janssen Pharmaceuticals, Inc ($327.10) |
| 2018 | $1,728 | 42 | Janssen Pharmaceuticals, Inc ($540.80) |
| 2017 | $673.72 | 21 | PFIZER INC. ($154.45) |
All Payment Transactions
180 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: DIABETES | ||||||
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $119.66 | General |
| Category: DIABETES | ||||||
| 10/08/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.88 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $7.80 | General |
| Category: DIABETES | ||||||
| 09/18/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $7.54 | General |
| Category: DIABETES | ||||||
| 08/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: DIABETES | ||||||
| 07/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $7.62 | General |
| Category: Diabetes | ||||||
| 07/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $2.54 | General |
| Category: Diabetes | ||||||
| 07/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: DIABETES | ||||||
| 07/01/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $5.66 | General |
| Category: Diabetes | ||||||
| 06/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: DIABETES | ||||||
| 06/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $7.20 | General |
| Category: Diabetes | ||||||
| 05/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $5.43 | General |
| Category: DIABETES | ||||||
| 05/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: Diabetes | ||||||
| 05/01/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: Diabetes | ||||||
| 04/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Diabetes | ||||||
| 04/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: DIABETES | ||||||
| 04/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: Diabetes | ||||||
| 03/27/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $7.63 | General |
| Category: Diabetes | ||||||
| 03/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Oncology | ||||||
| 03/18/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $31.47 | General |
| Category: Diabetes | ||||||
| 03/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 483 | 833 | $65,909 | $42,353 |
| 2022 | 14 | 682 | 1,007 | $83,566 | $54,436 |
| 2021 | 14 | 526 | 899 | $67,535 | $41,877 |
| 2020 | 16 | 533 | 937 | $61,777 | $37,685 |
Total Patients
2,224
Total Services
3,676
Medicare Billing
$176,351
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 108 | 217 | $23,795 | $15,004 | 63.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 65 | 70 | $14,700 | $9,925 | 67.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 45 | 45 | $6,800 | $6,316 | 92.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 62 | 89 | $6,230 | $3,636 | 58.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 19 | $2,850 | $1,923 | 67.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 11 | 24 | $2,500 | $1,225 | 49.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $1,820 | $1,056 | 58.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 24 | 26 | $910.00 | $868.92 | 95.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 11 | 13 | $1,300 | $753.37 | 58.0% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 18 | 20 | $700.00 | $630.90 | 90.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 41 | 45 | $2,925 | $557.04 | 19.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 38 | 46 | $690.00 | $386.40 | 56.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 14 | 93 | $465.00 | $61.81 | 13.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 17 | 112 | $224.00 | $8.87 | 4.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 95 | 196 | $21,560 | $13,636 | 63.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 89 | 89 | $13,350 | $12,756 | 95.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 85 | 86 | $18,060 | $12,411 | 68.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 48 | $7,200 | $4,673 | 64.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 62 | 99 | $6,930 | $4,072 | 58.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 17 | 32 | $3,200 | $1,732 | 54.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 41 | 41 | $1,425 | $1,352 | 94.9% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 42 | 42 | $1,470 | $1,252 | 85.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 74 | 78 | $5,070 | $883.54 | 17.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 11 | 17 | $1,700 | $862.80 | 50.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 12 | 79 | $1,640 | $423.93 | 25.8% |
About Dr. Greg Brown, M.D
Dr. Greg Brown, M.D is a Internal Medicine healthcare provider based in San Clemente, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1720135346.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Greg Brown, M.D has received a total of $5,840 in payments from pharmaceutical and medical device companies, with $777.62 received in 2024. These payments were reported across 180 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($5,695).
As a Medicare-enrolled provider, Brown has provided services to 2,224 Medicare beneficiaries, totaling 3,676 services with total Medicare billing of $176,351. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location San Clemente, CA
- Active Since 01/04/2007
- Last Updated 12/16/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1720135346
Products in Payments
- XARELTO (Drug) $886.19
- MOUNJARO (Drug) $464.59
- Ozempic (Drug) $399.93
- JARDIANCE (Drug) $356.19
- FARXIGA (Drug) $273.98
- INVOKANA (Drug) $264.09
- Rybelsus (Drug) $201.96
- Epclusa (Drug) $200.03
- ELIQUIS (Drug) $180.52
- Vascepa (Drug) $166.85
- CHANTIX (Drug) $147.30
- Victoza (Drug) $140.16
- FASENRA (Drug) $126.62
- Tresiba (Drug) $124.99
- SHINGRIX (Drug) $124.62
- Carto Smarttouch (Device) $124.30
- ABILIFY (Drug) $122.68
- UBRELVY (Drug) $118.51
- DUPIXENT (Biological) $118.39
- TRULICITY (Drug) $105.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in San Clemente
Kenneth Rexinger, M.d, M.D
Internal Medicine — Payments: $4,533
Internal Medicine $4,533
Lawrence Chang, M.d, M.D
Internal Medicine — Payments: $4,461
Internal Medicine $4,461
Torsten Kruse, M.d, M.D
Internal Medicine — Payments: $3,478
Internal Medicine $3,478
Steven Cullen, Md, MD
Internal Medicine — Payments: $1,178
Internal Medicine $1,178
Karen Garner, Md, MD
Internal Medicine — Payments: $997.07
Internal Medicine $997.07
Yelena Wood, M.d, M.D
Internal Medicine — Payments: $803.37
Internal Medicine $803.37